NCT01374178 A Comparison of LY2963016 to a Basal Insulin After a Single Dose in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01373216 Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass Status COMPLETED Phase PHASE3
NCT01373164 A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01372085 Single Dose Study in Healthy Participants to Investigate the Safety and Absorption of LY2584702 Status COMPLETED Phase PHASE1
NCT01370499 A Study of LY2216684 in Participants With Major Depression Disorder Status COMPLETED Phase PHASE3
NCT01370005 12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT01369511 A Study of LY2495655 in Older Participants Undergoing Elective Total Hip Replacement Status COMPLETED Phase PHASE2
NCT01368081 Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT01367262 Disposition of Carbon-14-Labeled LY2886721 ([^14C]-LY2886721) Following Oral Administration in Healthy Human Participants Status COMPLETED Phase PHASE1
NCT01364584 Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes Status COMPLETED Phase NA
NCT01363284 Pretreatment Identification of Duloxetine Success in Neuropathic Pain Patients Status COMPLETED Phase NA
NCT01360424 Teriparatide Treatment in Patients With Inherited Osteoporosis Status COMPLETED Phase PHASE4
NCT01358981 A Study of LY2881835 in Healthy People and People With Diabetes Status COMPLETED Phase PHASE1
NCT01358968 A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pathway of Desipramine Status COMPLETED Phase PHASE1